The use of agonistic anti-CD40 therapy in treatments for cancer

QR Code

The use of agonistic anti-CD40 therapy in treatments for cancer

Agonistic anti-CD40 antibody is a potent stimulator of anti-tumor immune responses due to itsaction on both immuneand tumor cells. It has the ability to “precondition” dendritic cells, allowingthem to prime effective cytotoxic T-cell responses. Thus, anti-CD40 antibody provides an idealtherapy for c...

Full description

Bibliographic Details
Main Authors:	Khong, A., Nelson, Delia, nowak, A., Lake, R., Robinson, B.
Format:	Journal Article
Published:	Taylor & Francis 2012
Subjects:	agonistic anti-CD40 immunotherapy mesothelioma cancer
Online Access:	http://informahealthcare.com/loi/iri http://hdl.handle.net/20.500.11937/49580

Similar Items

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
by: Jackaman, Connie, et al.
Published: (2013)

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ - independent resolution of treated-turmors and CD4+ -dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)

IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014)

Citrullinated α-enolase is an effective target for anti-cancer immunity
by: Cook, Katherine, et al.
Published: (2018)

Determination of agonist intrinsic efficacies at the dopamine D2 receptor
by: Stott, Lisa Alice
Published: (2017)

Safety aspect of β2-agonists in chronic obstructive pulmonary diesease
by: Whale, Christopher Ian
Published: (2009)

Understanding the biology Of CD24
by: Sajid, Saira
Published: (2018)

Investigating the signalling and functional activity of CD24 in cancer
by: Otifi, Hassan
Published: (2017)

Development of Cancer Immunotherapeutics Targeting Complement Regulatory Protein CD55
by: Bradley, Richard Grayson
Published: (2007)

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
by: Jackaman, Connie, et al.
Published: (2013)

Regulation of ige-mediated mast cell degranulation in allergy by geranyl acetophenone
by: Tan, Ji Wei
Published: (2017)

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
by: Xue, Wei, et al.
Published: (2016)

Part A - PD-1/PD-L1 blockade in cancer immunotherapy/ Part B - Evaluation of PD-1/PD-L1 immune checkpoint inhibitors in a luciferase-reporter cell-based assay
by: Peredo Aguilar, Maria Azucena
Published: (2023)

Development of lactococcus lactis vaccine vectors against breast carcinoma
by: Baradaran, Ali
Published: (2015)

Advancing the clinical implementation of Clostridial cancer therapies
by: Zygouropoulou, Maria
Published: (2019)

Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma
by: Patel, Mitesh, et al.
Published: (2014)

Effects of autophagy inhibition on Newcastle disease virus-induced oncolysis in breast cancer cells
by: Rozilah, Megat Mohamad Irfan
Published: (2022)

Changing health behaviour with rehabilitation in thoracic cancer: a systematic review and synthesis
by: Bayly, Jo, et al.
Published: (2018)

Histopathological analysis of CD44 and c-Myc in colorectal cancer
by: Littlewood, Stephanie
Published: (2021)

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
by: Jackaman, Connie, et al.
Published: (2012)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

Synthesis of ganoderic acid analogues to investigate their activity as anti-prostate cancer agents
by: Al-Obaidi, Mohammed
Published: (2019)

The potential for repurposing α2-adrenoceptor agonists and noradrenaline uptake1 inhibitors in the management of septic shock
by: Benyamen, Julian
Published: (2024)

Detection of Beta-Agonist Residues in Meat Using Enzyme Linked Immunosorbent Assay and Gas Chromatography Mass Spectrometry
by: S. Ponniah, P. Jeyaletchumi
Published: (2003)

Investigation of the role of CD24 gene in the progression of colorectal cancer
by: Hakami, Zaki
Published: (2021)

Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy
by: Haque, Nazmul, et al.
Published: (2013)

CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer
by: Raposo, T.P., et al.
Published: (2018)

Novel orlistat LDL-like nanoparticles as potential anti-cancer medicines
by: Bebawy, George
Published: (2022)

Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist
by: Stoddart, Leigh A., et al.
Published: (2015)

Biomedical application of OrbiSIMS in cancer: identification of anti-cancer agents and metabolite profiles
by: Lu, Yonghui
Published: (2023)

Induction of apoptosis in murine malignant mesothelioma cell lines: gene expression and susceptibility
by: Kusmiaty
Published: (2003)

Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma
by: De Santo, Carmela, et al.
Published: (2018)

Within and between day repeatability of the incremental shuttle walking test in patients with thoracic cancer
by: Wilcock, Andrew, et al.
Published: (2018)

A review of standard pharmacological therapy for adult asthma - Steps 1 to 5
by: Patel, Mitesh Dilipkumar Kantilal, et al.
Published: (2015)

Living with mesothelioma: A systematic review of patient and caregiver psychosocial support needs
by: Breen, Lauren, et al.
Published: (2022)

Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
by: Patel, Poulam M., et al.
Published: (2018)

Differential effects of short-term β agonist and growth hormone treatments on expression of myosin heavy chain IIB and associated metabolic genes in sheep muscle
by: Hemmings, K.M., et al.
Published: (2014)

Enhanced dendritic cell immunotherapy to treat glioblastoma
by: Adhikaree, Jason
Published: (2019)

Novel oral targeted therapies in inflammatory bowel disease
by: White, Jonathan Richard, et al.
Published: (2018)

Autoantibodies and cancer among asbestos-exposed cohorts in Western Australia
by: Carey, Renee, et al.
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gl2olpq6nocn1ukducan3sc51u